ESTA

During the quarter, we initiated a position in Jersey Mike's Subs Inc., a franchisor of fast casual, submarine-style sandwich restaurants. We participated in the IPO of Lyntris Inc., a fast-growing proprietary defense solutions provider with a 90% sole-sourced portfolio exposed to many of the nation's key defense offerings. We sold our position in Wingstop Inc. during the quarter to allocate the proceeds into other restaurant companies where we felt there was better upside potential.

Establishment Labs Holdings Inc. (ESTA) Q3 2026 Earnings Call Transcript

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.38 per share a year ago.

Establishment Labs NASDAQ: ESTA reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the company generated positive free cash flow for the first time in its history.

Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs is leveraging FDA approval and U.S. market entry to drive higher-margin growth through procedure-based offerings like Preservé. Q2 2026 results showed 31.7% revenue growth, gross margin expansion to 70.6%, and U.S. sales accounting for 89% of total growth. Preservé delivers over 2x revenue per procedure versus traditional augmentation, but long-term success hinges on repeat utilization and durable economics.

Establishment Labs NASDAQ: ESTA reported second-quarter revenue growth of 31.7% year over year, driven by continued rapid expansion in the United States, rising adoption of its Minimally Invasive platform and improving operating leverage.

Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $0.57 per share a year ago.

NEW YORK--(BUSINESS WIRE)---- $ESTA #Breast--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 6, 2026, and will host a conference call at 8:30 AM ET that day to discuss those results. To participate in the conference call, Dial: (+1) 888-396-8049 (US &amp.

JW Asset Management sold 90,533 shares between May 26 and May 28, 2026, generating a transaction value of ~$6.64 million at a weighted average price of around $73.31 per share. The transaction represented 3.04% of the insider's total indirect holdings, reducing indirect ownership from ~2.98 million to ~2.89 million shares.